IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead therapeutic cancer vaccine candidate includes IO102-IO103, which...
Leadership
Mai-Britt Zocca Ph.D.Founder
Founder, President, CEO, Principal Financial Officer & Director
Amy B. Sullivan M.B.A.
Principal Accounting Officer & CFO
Inge Marie Svane M.D., Ph.D.Founder
Founder & Clinical Advisor
Mads Hald Andersen M.D., Ph.D.Founder
Co-Founder & Scientific Advisor
Anders LjungqvistFounder
Founder
Per Thor StratenFounder
Founder
Eric Faulkner M.B.A., M.Sc.
Chief Technical Officer
Devin Whittemore Smith J.D.
Secretary, General Counsel & Chief Compliance Officer